Humaira is an associate in the firm’s New Jersey office. Her practice focuses on plaintiff litigation in product and medical device liability and pharmaceutical drug injury in mass torts.
Bio
Education
2013, Juris Doctor
Charlotte School of Law
2010, Bachelor of Arts
Temple University
Languages
Urdu
Practices
Admissions
States
- New Jersey
District Courts
- District of New Jersey
Selected Representation
Prior results do not guarantee or predict a similar outcome in any future matter.
Member of the Seeger Weiss team appointed by the Hon. Rebecca F. Doherty to the Plaintiffs’ Steering Committee of the consolidated multi-district litigation (MDL), obtaining a jury verdict of $9 billion in punitive damages, the seventh-largest verdict in US history (later reduced to $36.8 million), against Takeda Pharmaceutical Co., Asia’s largest drug maker, and marketing partner Eli Lilly & Co., on behalf of plaintiffs who developed bladder cancer resulting from their Actos diabetes drug. Involvement included case evaluations, discovery responsibilities and settlement process.
Member of the Seeger Weiss team appointed by the Hon. Brian R. Martinotti as Co-Lead Counsel of the Plaintiffs’ Steering Committee, representing plaintiffs in consolidated MDL and state court litigation against Johnson & Johnson Co. and Janssen Pharmaceuticals, Inc., claiming injuries including diabetic ketoacidosis, acute kidney failure and amputations as a result of taking the drug Invokana. Involvement has included case evaluations and discovery responsibilities. Case pending.
Representing plaintiffs in MDL and state court proceedings against Bard Medical Division, manufacturers of the blood filter IVC Filter, for serious and potentially permanent injuries including perforation, migration and/or fractured struts. Involvement has included case evaluation and discovery responsibilities. Case pending.
Representing plaintiffs in MDL and state court proceedings against Cook Medical Inc., manufacturers of the blood filter IVC Filter, for serious and potentially permanent injuries including perforation, migration and/or fractured struts. Involvement has included case evaluation and discovery responsibilities. Case pending.
Prior results do not guarantee or predict a similar outcome in any future matter.
Representing plaintiffs in an MDL of nearly 1000 lawsuits against Daiichi Sankyo Co. Ltd. and Forest Laboratories Inc., manufacturers of blood pressure medication Benicar, for gastrointestinal injuries sustained after using the drug. Involvement included case evaluation, discovery responsibilities, and evaluating cases for settlement. Settlement pending.
Representing plaintiffs in MDL against the manufacturers of Physiomesh who have suffered an injury from the mesh product. Involvement has included case evaluations, and discovery responsibilities. Case pending.